Booster Dose of sIPV Co-administered With MMR and HepA-I.

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

960

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

February 10, 2025

Study Completion Date

March 10, 2025

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

sIPV

vaccination with sIPV

BIOLOGICAL

MMR

vaccination with MMR

BIOLOGICAL

HepA-I

vaccination with HepA-I

Trial Locations (1)

Jiangsu Center for Disease Control and Prevention (Jiangsu Institute of Public Health), Nanjing

All Listed Sponsors

lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT06442449 - Booster Dose of sIPV Co-administered With MMR and HepA-I. | Biotech Hunter | Biotech Hunter